CHIJI JON-UBABUCO: Open Payments
NPI 1043804487 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 30 payments from 7 companies in 2025. Trend: 2023 $410 · 2024 $102 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $233 |
| Axsome Therapeutics, Inc. | 9 | $150 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 1 | $115 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Corium, LLC | 1 | $21 |
| Alkermes, Inc. | 1 | $14 |
Products named: VRAYLAR, Auvelity, ABILIFY ASIMTUFII, INVEGA SUSTENNA, COBENFY, Azstarys, ARISTADA.
Industry payments across TX — which companies pay providers there.
